Pricing

MyoKardia Inc (MYOK)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Anastasios E. Gianakakos
Employees:
165
1000 SIERRA POINT PARKWAY, BRISBANE, CA, 94005
650-741-0900

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

MyoKardia, Inc. operates as a biopharmaceutical company which engages in the discovery, development, and commercialization of targeted therapies for the treatment of cardiovascular diseases. It offers MYK-46, an orally-administered small molecule designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy. The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available